MELA Sciences named best idea at Stephens Stephens made MELA Sciences its best idea after channel checks indicated early launch of the company's MelaFind technology is progressing very well. Stephens believes MELA shares are pricing in little chance of commercial success and sees minimal downside at current levels. The firm keeps an Overweight rating on the stock with a $10 price target.
News For MELA From The Last 14 Days
Check below for free stories on MELA the last two weeks.